A Phase I, Open-Label Study of MOXR0916 in Patients With Locally Advanced or Metastatic Solid Tumors

Clinical Trial ID NCT02219724

PubWeight™ 4.12‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02219724

Top papers

Rank Title Journal Year PubWeight™‹?›
1 PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations. Sci Transl Med 2016 2.16
2 Advances in targeted and immunobased therapies for colorectal cancer in the genomic era. Onco Targets Ther 2016 0.81
3 New Strategies in Bladder Cancer: A Second Coming for Immunotherapy. Clin Cancer Res 2015 0.78
4 Immune Checkpoint Modulation in Colorectal Cancer: What's New and What to Expect. J Immunol Res 2015 0.78
Next 100